Clearmind Medicine Inc.

Healthcare · Biotechnology · Canada

Last price 5.85 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.46M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; a...